CEACAM8 and lung cancer: Flow cytometric analysis revealed a dramatic increase in the expression of the immunosuppressive marker PD-L1 on CD66b+ neutrophils from lung cancer patients (97.5% ± 5.4%) compared to healthy controls (52.3% ± 24.9%),p < 0.0001 as shown in Figure 3B – left panel.